Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Lundbeck

37.48 DKK

-0.11 %

Less than 1K followers

HLUN B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lundbeck

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

Dividend yield

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (DKK)50.8841.7633.7726.0532.7641.3243.16
Shares993.5993.5993.5995.7995.7995.7992.1
Market cap50,549.341,488.633,550.525,939.132,620.541,144.042,821.2
Enterprise value57,115.345,594.636,739.527,970.131,761.553,173.0-
EV/S3.42.62.31.51.62.4-
EV/EBITDA11.89.59.96.06.110.3-
EV/EBIT15.822.918.39.89.916.3-
P/E19.026.225.513.514.213.013.4
P/B3.472.441.841.251.481.651.72
P/S3.02.32.11.41.61.91.7
Dividend yield1.6 %1.2 %1.2 %2.2 %2.1 %2.3 %2.7 %
Equity ratio40.7 %47.1 %52.7 %55.5 %58.9 %43.9 %47.8 %
Gearing ratio74.6 %43.6 %29.1 %26.8 %18.8 %66.7 %46.8 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.